{"DataElement":{"publicId":"65174","version":"3","preferredName":"Upper GI Tumor Pathologic M Stage","preferredDefinition":"absence or presence of distant metastasis as determined prior to treatment based on evidence of tumor in microscopic examination of distant lesions.","longName":"UPPERGI_TUMOR_P_M_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192276","version":"1","preferredName":"Upper GI Tumor Pathologic M Stage","preferredDefinition":"information related to pathologic M stage for an upper GI tumor.","longName":"UPPERGI_TUMOR_P_M","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206811","version":"1","preferredName":"Upper GI Neoplasm","preferredDefinition":"Upper Gastrointestinal Tract Radiography is an x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C17639:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Gastrointestinal Series","conceptCode":"C17639","definition":"An x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0575-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207807","version":"1","preferredName":"Pathologic M Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  M refers to the presence of metastasis.","longName":"C25610:C25727","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"M Category","conceptCode":"C25727","definition":"One criteria of the TNM staging system. M refers to the presence of metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-30F5-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E915505A-2B58-0390-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-17","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-17","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018462","version":"1","preferredName":"Upper GI Tumor Pathologic M Stage","preferredDefinition":"the pathologic M (metastasis) stage of an upper GI (gastrointestinal) tumor, including pancreas and esophagus.","longName":"UPPERGI_TUMOR_P_M_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"M0","valueDescription":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2559520","version":"1","preferredName":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","longName":"2559520","preferredDefinition":"NO DISTANT METASTASES ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B58D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662752-C45D-43BC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"M1","valueDescription":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2558672","version":"1","preferredName":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","longName":"2558672","preferredDefinition":"DISTANT METASTASES PRESENT ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662752-C45F-43BC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"MX","valueDescription":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","ValueMeaning":{"publicId":"2558671","version":"1","preferredName":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","longName":"2558671","preferredDefinition":"DISTANT METASTASES PRESENCE OR ABSENCE CANNOT BE ASSESSED ACCORDING TO AJCC GUIDELINES","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B23C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD662752-C461-43BC-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2004-06-21","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B44BAB46-DA47-4B6E-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-15","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-15","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":"6/21 - values added that were omitted during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811789","version":"1","longName":"Adjuvant Esophageal","context":"CTEP"},{"publicId":"2811790","version":"1","longName":"Adjuvant Gastric","context":"CTEP"},{"publicId":"2811792","version":"1","longName":"Advanced Esophageal","context":"CTEP"},{"publicId":"10000446","version":"1","longName":"Advanced Gastric","context":"CTEP"},{"publicId":"2811827","version":"1","longName":"Unresect Pancreatic","context":"CTEP"},{"publicId":"2811829","version":"1","longName":"Resect Pancreatic","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]}],"AlternateNames":[{"name":"UPPERGI_TUMOR_P_M_ST","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"M Stage, Pathologic","url":null,"context":"CTEP"},{"name":"Pathologic M Stage","type":"Preferred Question Text","description":"Pathologic M Stage","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B45E9FFA-B3BD-02C0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-16","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-16","modifiedBy":"FORMBUILDER","dateModified":"2014-07-15","changeDescription":"ISO 11179 Compliance; values added that were omitted during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}